Side Effects of bb-Interferon: A Comparative Study Among Avonex, Betaseron and Rebif Side effects of b-interferon
Iranian Journal of Pharmaceutical Sciences,
مجلد 1 عدد 3 (2005),
1 July 2005
,
الصفحة 177-182
https://doi.org/10.22037/ijps.v1.39510
الملخص
The administration of b-interferon is a recognized treatment for multiple sclerosis. The frequency of side effects is an important factor in drug or product selection. In this study, the side effects of three available b-interferon products are compared in 122 multiple sclerosis patients who were treated with b-interferon products for at least three months and had the Expanded Disability Status Scale (EDSS) between 1 and 6. The frequencies of side effects were determined for each group and the collected information were compared in the three treated groups. Fever, chills, headache, malaise and asthenia were the most frequent observed complications. Necrosis at the injection site was seen only in Betaseron group. Somnolence was more frequent with the administration of Avonex. Gastro-intestinal disturbances were less frequent in patients treated with Rebif. Weight gain was more frequent in patients treated with Avonex, and seizure and migraine were observed only in this group.Urticaria and hypersensitivity skin reactions were less frequent with the administration of Avonex. Rebif may be a better choice for patients with gastrointestinal disturbances, suicidal attempts and chronic fatigue syndrome. Avonex may be better tolerated in patients with a history of urticaria and hypersensitivity skin reactions, but it is less recommended for patients with a history of seizure, migraine and syncope. Betaseron may be a better choice in patients with a history of chest pain and hypertension.
- b-Interferon
- Multiple Sclerosis
- Side effects
كيفية الاقتباس
المراجع
[2] Aslam AK, Singh T. Aplastic anemia associated with interferon b-1a. Am J Ther 2002; 9: 522-3.
[3] Zivadinov R, Zorzon M, Tommasi MA, Nasuelli D, Bernardi M, Monti-Bragadin L, Cazzato G. A longitudinal study of quality of life and side effects in patients with multiple sclerosis treated with interferon beta-la. J Neurol Sci 2003; 216: 113-8.
[4] Montalban X, Duran I, Rio J, Saez-Torres I, Tintore M, Martinez- caceres EM. Can we predict flu-like symptoms in patients with multiple sclerosis treated with interferon-beta? J Neurol 2000; 247: 259-62.
[5] Lofits JM, Hauser P. The phenomenology and treatment of interferon-induced depression. J Affect Disord 2004; 82:175-90.
[6] Garcia-F-Villalta M, Dauden E, Sanchez J, Fraga J, Ramo C, Garcia- Diez A. Local reactions associated with subcataneus injections of betainterferon. Acta Derm Venereol 2001; 81: 152.
[7] Brown DL, Login IS, Borish L, Powers PL. An urticarial IgE-mediated reaction to interferon beta-1b. Neurology 2001; 56: 1416-7.
[8] Mazzeo L, Ricciardi L, Fazio MC, Fogliani O, Fedele R, Ferlazzo E, Isola S. Severe urticaria due to recombinant interferon beta-1a. Br J Dermatol 2003; 148: 172.
[9] Creange A, Lefaucheur JP. Focal neuropathy associated with cutaneus necrosis at the site of interferon-beta injection for multiple sclerosis. J Neurol Neurosurg Psychiatry 2000; 68: 395.
[10] Casoni F, Merelli E, Bedin R, Martella A, Casinaro A, Bertolotto A. Necrotizing skin lesions and NABs development in a multiple sclerosis patient treated with IFNbeta 1b. Mult Sclor 2003; 9: 420-3.
[11] Cooper CL, Gerstein R, Kaita K. Fascitis complicating subcutaneous injection of interferon beta. Can J Gastroenterol 2000; 14: 81B- 2B.
[12] Cruz BA, Queiroz ED, Nunes SV, Cruz A, Campos GB, Monteiro EL, Grivellari H. Severe Raynaud’s phenomenon associated with interferon beta therapy for multiple sclerosis: a case report. Arq Neuropsiquiatr 2000; 58: 556-9.
[13] Kourakata H, Tanabe Y, Mikami O, Sato K, Suzuki E. A case of interferon beta-induced pneumonia. Nihon Kokyuki Gakkai Zasshi 2000; 38: 687-91.
[14] Lunemann JD, Schwarzenberger B, Kasim N, Zschenderlein R, Zipp F. Rhabdomyolysis during interferon–beta 1a treatment. J Neurol Neurosurg Psychiatry 2002; 72: 274.
[15] Tola MR, Caniatti IM, Graganiello J, Russo M, Stabellini M, Granieri E. Recurrent nephritic syndrome in patients with multiple sclerosis treated with interferon beta 1a. J Neurol 2003; 250: 768-9.
[16] Gotsman L, Elhallel-Darnitski M, Friedlander Z, Haviv YS. Beta-interferon-induced nephritic syndrome in a patient with multiple sclerosis. Clin Nephrol 2000; 54: 425-6.
[17] Altintas A, Alici Y, Melikoglu M, Sira A. Arthritis during interferon beta-1b treatment in multiple sclerosis. Mult Scler 2002; 8: 534-6.
[18] Dubisar BM, Stoner SC, Khan R, Farrar CD. Seizures and extra pyramidal symptoms in a patient with Tourett’s syndrome, Asperger syndrome, and multiple sclerosis treated with interferon beta-1a and clomipramine. Pharmacol 2002; 22: 1504-7.
[19] Sommer S, Sablon JC, Zaouri M, Rozot P, Hosni A. Interferon beta-1b retinopathy during a treatment for multiple sclerosis. J Fr Ophtalmol 2001; 24: 509-12.
[20] McDonald ND, Pender MP. Autoimmune hypothyroidism associated with interferon beta- 1b treatment in two patients with multiple sclerosis. Aust N Z J Med 2000; 30: 278-9.
[21] Kado S, Miyamoto J, Komatsu N, Iwaki Y, Ozaki H, Tagnchi H, Kure M, Sarashina G, Watanabe T, Katsura Y, Nemoto Y, Noritake M, Matsuoka T. Type 1 diabetes mellitus caused by treatment with interferon-beta. Intern Med 2000; 39: 146-9.
[22] Watts RA. Musculuskeletal and systemic reactions to biological therapeutic agents. Curr Opin Rheumatol 2000; 12: 49-52.
[23] Kazuta Y, Watanabe N, Sagawa K, Kobayashi H, Kojima T, Funabashi H, Moritoh T, Kasukawa R. Acase of autoimmune hemolytic anemia induced by IFN-beta therapy for Type-C chronic hepatitis. Fukushima J Med Sci 1995; 41: 43-9.
[24] Goeb JL, Cailleau A, Laine P, Etcharry-Bouyx F, Mangin D, Duverger P, Gohier B, Rannou-Dubas K, Dubas F, Garre JB. Acute delirium, delusion, and depression during IFN-beta-1a therapy for Multiple sclerosis. Clin Neuropharmacol 2003; 26: 5-7.
[25] Pandya R, Patten S. Depression in multiple sclerosis associated with interferon-beta-1a. Can J Psychiatry 2002; 47: 686.
[26] Lana-Peixoto MA, Teixeira AL, Haase VG. Interferon-beta-1a-induced depression and suicidal ideation in multiple sclerosis. Arg Neuropsiquiatr 2002; 60: 721-4.
- الملخص المشاهدات: 85 الأوقات
- IJPS_Volume 1_Issue 3_Pages 177-182 (English) التنزيلات: 17 الأوقات